Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review

Pulmonary arterial hypertension‐targeted therapies in portopulmonary hypertension (PoPH) are scarce, let alone for patients with chronic liver failure (CLF) and hepatopulmonary syndrome (HPS). A 48‐year male was admitted to the hospital because of cirrhosis for 18 years, systemic oedema, and chest d...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Niuniu, Wu, Qiang, Meng, Juan, Feng, Cheng, Jiang, Siwei, Chen, Meixia, Xu, Wenhui, Wang, Fei, Zhang, Yifan, Liu, Juncai, Xu, Cheng, Liu, Gaolin, Gao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375108/
https://www.ncbi.nlm.nih.gov/pubmed/37313579
http://dx.doi.org/10.1002/ehf2.14431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375108/
https://www.ncbi.nlm.nih.gov/pubmed/37313579
http://dx.doi.org/10.1002/ehf2.14431

Ejemplares similares